Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Sexual dysfunction Stories

2012-12-31 05:00:15

Next Status conference in New Jersey Propecia litigation scheduled for January 10, 2013. New York, New York (PRWEB) December 30, 2012 Propecia lawsuits alleging use of the drug caused men to suffer persistent sexual side effects continue to move forward in a consolidated litigation now underway in New Jersey Superior Court, Middlesex County. According to court records, 248 claims are pending in the New Jersey Propecia litigation, and the proceeding´s next Status Conference is...

2012-12-04 12:07:42

Men in their thirties who had inflamed gums caused by severe periodontal disease were three times more likely to suffer from erection problems, according to a study published in the Journal of Sexual Medicine. Turkish researchers compared 80 men aged 30 to 40 with erectile dysfunction with a control group of 82 men without erection problems. This showed that 53 per cent of the men with erectile dysfunction had inflamed gums compared with 23 per cent in the control group. When the...

2012-11-13 12:29:24

PETACH TIKVA, Israel, Nov. 13, 2012 /PRNewswire/ -- Can-Fite BioPharma (TASE: CFBI, OTC: CANFY), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it designated the CF602 drug, which was licensed from the Leiden University, to be developed for the treatment of sexual dysfunction. During clinical studies conducted with other drugs of the company, patients suffering from sexual dysfunction...

2012-11-08 08:34:25

CRANBURY, N.J., Nov. 8, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) today reported positive top-line results, including the successful achievement of statistical significance for the primary endpoint and key secondary endpoints in its Phase 2B clinical trial evaluating the efficacy and safety of bremelanotide for the treatment of female sexual dysfunction (FSD). The data demonstrate that women taking bremelanotide showed statistically significant increases in the number...

2012-10-31 03:33:51

An Indiana University study has found that women undergoing in-vitro fertilization report that the process of infertility treatment has many negative impacts on their sexual relationship with their partner. Little attention has been given to the sexual dynamics of couples as they navigate infertility and treatments such as IVF, despite the important role that sex plays in a couple's attempt to conceive a child. "Sex is for pleasure and for reproduction, but attention to pleasure often goes...

2012-10-30 07:26:50

INDIANAPOLIS, Oct. 30, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Commission has approved Cialis 5 mg for once daily use for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Cialis was approved for erectile dysfunction (ED) in the EU in 2002. Cialis for once daily use was approved to treat ED in the EU in 2007. "With this approval, Cialis is now the only medication in the EU to provide a single treatment option for...

2012-09-30 23:03:48

A new fast-acting erectile dysfunction medication is generating a lot of buzz. It´s been ten years since a new erectile dysfunction medication has hit the market, and AccessRx.com will offer Stendra as soon as it´s available later this year. Tempe, Arizona (PRWEB) September 30, 2012 A new fast-acting erectile dysfunction medication is generating a lot of buzz. It´s been ten years since a new erectile dysfunction medication has hit the market, and AccessRx.com will offer...

2012-09-26 10:23:50

SADDLE BROOK, N.J., Sept. 26, 2012 /PRNewswire/ -- Erectile Doctor, a website that provides men with privacy and discretion when seeking erectile dysfunction treatment, attended the SMSNA and ISSM 2012 World Meeting on Sexual Medicine in Chicago, IL, on Aug. 26-30 with XION Medical, a men's health company with products based on scientific literature. Attendees included scientists, urologists and a plethora of mental and physical health care professionals specialized in sexual health. The...

2012-09-21 02:23:47

INDIANAPOLIS, Sept. 21, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending approval of Cialis® (tadalafil) tablets 5 mg for once a day use for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). The CHMP's opinion is now referred to the European Commission, which has the authority to approve...

2012-09-21 02:23:41

INDIANAPOLIS, Sept. 21, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today it has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in the European Union (EU), recommending approval of Cialis 5 mg for once daily use for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). The opinion is now referred for final action to the European Commission, which has the authority to approve medicines for the EU. The...